Form 8-K - Current report:
SEC Accession No. 0001104659-25-101535
Filing Date
2025-10-22
Accepted
2025-10-22 16:13:53
Documents
15
Period of Report
2025-10-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gbio-20251021x8k.htm   iXBRL 8-K 46066
2 EX-99.1 gbio-20251021xex99d1.htm EX-99.1 9374
3 GRAPHIC gbio-20251021xex99d1001.jpg GRAPHIC 3927
  Complete submission text file 0001104659-25-101535.txt   178790

Data Files

Seq Description Document Type Size
4 EX-101.SCH gbio-20251021.xsd EX-101.SCH 3398
5 EX-101.DEF gbio-20251021_def.xml EX-101.DEF 2738
6 EX-101.LAB gbio-20251021_lab.xml EX-101.LAB 13970
7 EX-101.PRE gbio-20251021_pre.xml EX-101.PRE 10836
17 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20251021x8k_htm.xml XML 4706
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

EIN.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39319 | Film No.: 251410277
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)